Journal Article DKFZ-2017-04526

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2014
National Acad. of Sciences Washington, DC

Proceedings of the National Academy of Sciences of the United States of America 111(1), 409 - 414 () [10.1073/pnas.1314469111]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: A hypoxic microenvironment induces resistance to alkylating agents by activating targets in the mammalian target of rapamycin (mTOR) pathway. The molecular mechanisms involved in this mTOR-mediated hypoxia-induced chemoresistance, however, are unclear. Here we identify the mTOR target N-myc downstream regulated gene 1 (NDRG1) as a key determinant of resistance toward alkylating chemotherapy, driven by hypoxia but also by therapeutic measures such as irradiation, corticosteroids, and chronic exposure to alkylating agents via distinct molecular routes involving hypoxia-inducible factor (HIF)-1alpha, p53, and the mTOR complex 2 (mTORC2)/serum glucocorticoid-induced protein kinase 1 (SGK1) pathway. Resistance toward alkylating chemotherapy but not radiotherapy was dependent on NDRG1 expression and activity. In posttreatment tumor tissue of patients with malignant gliomas, NDRG1 was induced and predictive of poor response to alkylating chemotherapy. On a molecular level, NDRG1 bound and stabilized methyltransferases, chiefly O(6)-methylguanine-DNA methyltransferase (MGMT), a key enzyme for resistance to alkylating agents in glioblastoma patients. In patients with glioblastoma, MGMT promoter methylation in tumor tissue was not more predictive for response to alkylating chemotherapy in patients who received concomitant corticosteroids.

Keyword(s): Antineoplastic Agents, Alkylating ; Cell Cycle Proteins ; Intracellular Signaling Peptides and Proteins ; N-myc downstream-regulated gene 1 protein ; O(6)-Methylguanine-DNA Methyltransferase ; MTOR protein, human ; TOR Serine-Threonine Kinases

Classification:

Contributing Institute(s):
  1. KKE Neuroonkologie (G370)
  2. KKE Neuropathologie (G380)
  3. Neuroimmunologie und Hirntumorimmunologie (G160)
  4. Kleintierbildgebung (W240)
  5. Biostatistik (C060)
  6. Funktionelle Proteomanalyse (B100)
  7. Translationale Radioonkologie (E210)
  8. DKTK Heidelberg (L101)
  9. DKTK Essen (L401)
  10. DKTK Berlin (L201)
Research Program(s):
  1. 317 - Translational cancer research (POF3-317) (POF3-317)

Appears in the scientific report 2014
Database coverage:
Medline ; BIOSIS Previews ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; National-Konsortium ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2017-10-17, last modified 2024-02-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)